R&D Briefing

CIRS RD Briefing 86 – Review of HTA outcomes and timelines in Australia, Canada and Europe 2017-2021

The Briefing presents data from HTADock, an ongoing metrics study that collects data on new active substances (NASs) appraised by eight HTA agencies and analyses synchronisation between the regulatory [...]

2025-12-10T11:45:00+00:00October 26th, 2022|Tags: , , |

CIRS RD Briefing 80 – Reimagining medicine regulatory models

This R&D Briefing summarises the outputs of breakout group discussions held during a CIRS multi-stakeholder workshop in December 2020 entitled ‘Reimagining medicine regulatory models: implementing fit-for-purpose sustainable activities for [...]

2026-05-29T10:33:41+00:00April 14th, 2021|Tags: , , |
Go to Top